In the most recent article on Gilead from Bloomberg, there was a interesting comment about new treatment that's pending FDA's approval. Is anybody familiar with that?
"The company (Gilead) expects only one more FDA approval this year, for one of its HIV treatments in hepatitis B, on top of three other approvals so far."
Full article: http://www.bloomberg.com/gadfly/articles/2016-07-26/gilead-earnings-gliding-s-not-enough?cmpid=yhoo.headline